Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia

Haematologica. 2012 Nov;97(11):1768-70. doi: 10.3324/haematol.2011.054957. Epub 2012 Jul 6.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anemia, Sickle Cell / blood*
  • Anemia, Sickle Cell / complications
  • Anticholesteremic Agents / administration & dosage*
  • Anticholesteremic Agents / adverse effects
  • Atorvastatin
  • Cholesterol / blood*
  • Cohort Studies
  • Female
  • Heptanoic Acids / administration & dosage*
  • Heptanoic Acids / adverse effects
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / etiology
  • Male
  • Middle Aged
  • Pyrroles / administration & dosage*
  • Pyrroles / adverse effects

Substances

  • Anticholesteremic Agents
  • Heptanoic Acids
  • Pyrroles
  • Cholesterol
  • Atorvastatin